Literature DB >> 24009073

A Bayesian approach to joint analysis of multivariate longitudinal data and parametric accelerated failure time.

Sheng Luo1.   

Abstract

Impairment caused by Parkinson's disease (PD) is multidimensional (e.g., sensoria, functions, and cognition) and progressive. Its multidimensional nature precludes a single outcome to measure disease progression. Clinical trials of PD use multiple categorical and continuous longitudinal outcomes to assess the treatment effects on overall improvement. A terminal event such as death or dropout can stop the follow-up process. Moreover, the time to the terminal event may be dependent on the multivariate longitudinal measurements. In this article, we consider a joint random-effects model for the correlated outcomes. A multilevel item response theory model is used for the multivariate longitudinal outcomes and a parametric accelerated failure time model is used for the failure time because of the violation of proportional hazard assumption. These two models are linked via random effects. The Bayesian inference via MCMC is implemented in 'BUGS' language. Our proposed method is evaluated by a simulation study and is applied to DATATOP study, a motivating clinical trial to determine if deprenyl slows the progression of PD.
© 2013 The authors. Statistics in Medicine published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  Markov chain Monte Carlo; clinical trial; failure time; item response theory; latent variable

Mesh:

Substances:

Year:  2013        PMID: 24009073      PMCID: PMC3947121          DOI: 10.1002/sim.5956

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  25 in total

1.  A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study.

Authors: 
Journal:  Arch Neurol       Date:  2002-12

2.  Pattern mixture models and latent class models for the analysis of multivariate longitudinal data with informative dropouts.

Authors:  Etienne Dantan; Cécile Proust-Lima; Luc Letenneur; Helene Jacqmin-Gadda
Journal:  Int J Biostat       Date:  2008       Impact factor: 0.968

3.  A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics.

Authors:  C Warren Olanow; Robert A Hauser; Joseph Jankovic; William Langston; Anthony Lang; Werner Poewe; Eduardo Tolosa; Fabrizio Stocchi; Eldad Melamed; Eli Eyal; Olivier Rascol
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

4.  Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach.

Authors:  C L Faucett; D C Thomas
Journal:  Stat Med       Date:  1996-08-15       Impact factor: 2.373

Review 5.  A review of multivariate longitudinal data analysis.

Authors:  S Bandyopadhyay; B Ganguli; A Chatterjee
Journal:  Stat Methods Med Res       Date:  2010-03-08       Impact factor: 3.021

6.  Model-based approaches to analysing incomplete longitudinal and failure time data.

Authors:  J W Hogan; N M Laird
Journal:  Stat Med       Date:  1997 Jan 15-Feb 15       Impact factor: 2.373

7.  Mixture models for the joint distribution of repeated measures and event times.

Authors:  J W Hogan; N M Laird
Journal:  Stat Med       Date:  1997 Jan 15-Feb 15       Impact factor: 2.373

8.  Analysis of longitudinal randomized clinical trials using item response models.

Authors:  Cees A W Glas; Hanneke Geerlings; Mart A F J van de Laar; Erik Taal
Journal:  Contemp Clin Trials       Date:  2008-12-24       Impact factor: 2.226

9.  A Bayesian semiparametric survival model with longitudinal markers.

Authors:  Song Zhang; Peter Müller; Kim-Anh Do
Journal:  Biometrics       Date:  2009-06-08       Impact factor: 2.571

10.  A rank-based sample size method for multiple outcomes in clinical trials.

Authors:  Peng Huang; Robert F Woolson; Peter C O'Brien
Journal:  Stat Med       Date:  2008-07-20       Impact factor: 2.373

View more
  10 in total

1.  Incorporating longitudinal biomarkers for dynamic risk prediction in the era of big data: A pseudo-observation approach.

Authors:  Lili Zhao; Susan Murray; Laura H Mariani; Wenjun Ju
Journal:  Stat Med       Date:  2020-07-27       Impact factor: 2.373

2.  Predicting Clinical Binary Outcome Using Multivariate Longitudinal Data: Application to Patients with Newly Diagnosed Primary Open-Angle Glaucoma.

Authors:  Feng Gao; J Philip Miller; Julia A Beiser; Chengjie Xiong; Mae O Gordon
Journal:  J Biom Biostat       Date:  2015-10-26

3.  Bayesian multivariate augmented Beta rectangular regression models for patient-reported outcomes and survival data.

Authors:  Jue Wang; Sheng Luo
Journal:  Stat Methods Med Res       Date:  2015-06-02       Impact factor: 3.021

4.  Joint modelling of longitudinal response and time-to-event data using conditional distributions: a Bayesian perspective.

Authors:  Srimanti Dutta; Geert Molenberghs; Arindom Chakraborty
Journal:  J Appl Stat       Date:  2021-03-09       Impact factor: 1.416

5.  Bayesian hierarchical model for multiple repeated measures and survival data: an application to Parkinson's disease.

Authors:  Sheng Luo; Jue Wang
Journal:  Stat Med       Date:  2014-06-17       Impact factor: 2.373

6.  Joint modeling of longitudinal zero-inflated count and time-to-event data: A Bayesian perspective.

Authors:  Huirong Zhu; Stacia M DeSantis; Sheng Luo
Journal:  Stat Methods Med Res       Date:  2016-07-26       Impact factor: 3.021

7.  Bayesian analysis of multi-type recurrent events and dependent termination with nonparametric covariate functions.

Authors:  Li-An Lin; Sheng Luo; Bingshu E Chen; Barry R Davis
Journal:  Stat Methods Med Res       Date:  2015-11-06       Impact factor: 3.021

8.  A flexible joint model for multiple longitudinal biomarkers and a time-to-event outcome: With applications to dynamic prediction using highly correlated biomarkers.

Authors:  Ning Li; Yi Liu; Shanpeng Li; Robert M Elashoff; Gang Li
Journal:  Biom J       Date:  2021-07-17       Impact factor: 2.207

9.  Joint modelling of time-to-event and multivariate longitudinal outcomes: recent developments and issues.

Authors:  Graeme L Hickey; Pete Philipson; Andrea Jorgensen; Ruwanthi Kolamunnage-Dona
Journal:  BMC Med Res Methodol       Date:  2016-09-07       Impact factor: 4.615

10.  Bayesian joint ordinal and survival modeling for breast cancer risk assessment.

Authors:  C Armero; C Forné; M Rué; A Forte; H Perpiñán; G Gómez; M Baré
Journal:  Stat Med       Date:  2016-08-14       Impact factor: 2.373

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.